Compare Stocks

→ Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MAV Pioneer Municipal High Income Advantage Fund	$7.84 +0.1%	$8.05	$6.37 ▼ $8.20	N/A	N/A	57,831 shs	83,211 shs
MPH Medicure	C$0.99 -3.9%	C$1.15	C$0.99 ▼ C$1.80	C$10.15M	1.01	4,370 shs	3,300 shs
PTL Inspire 500 ETF	$193.04 +1.1%	$0.00	$189.17 ▼ $205.92	N/A	N/A	33,555 shs	12,639 shs

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MAV Pioneer Municipal High Income Advantage Fund	+0.19%	-0.38%	-3.80%	0.00%	-1.13%
MPH Medicure	0.00%	-8.33%	-13.91%	-13.91%	-23.85%
PTL Inspire 500 ETF	+1.09%	+0.23%	+19,303,999,900.00%	+19,303,999,900.00%	+19,303,999,900.00%

Elon Musk’s Controversial New Project: “Apollo” (Ad)

Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...

Click here to see the details because there's a lot of money at stake.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MAV Pioneer Municipal High Income Advantage Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MPH Medicure	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PTL Inspire 500 ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MAV Pioneer Municipal High Income Advantage Fund	N/A	N/A	N/A	N/A
MPH Medicure	N/A	N/A	N/A	N/A
PTL Inspire 500 ETF	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MAV Pioneer Municipal High Income Advantage Fund	$-675.71K	N/A	N/A	N/A	N/A	N/A
MPH Medicure	C$22.94M	0.44	C$0.40 per share	2.49	C$2.10 per share	0.47
PTL Inspire 500 ETF	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MAV Pioneer Municipal High Income Advantage Fund	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MPH Medicure	C$1.08M	C$0.09	11.00	∞	N/A	4.71%	5.04%	2.49%	5/24/2024 (Estimated)
PTL Inspire 500 ETF	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MAV Pioneer Municipal High Income Advantage Fund	$0.34	4.34%	N/A	N/A	N/A
MPH Medicure	N/A	N/A	N/A	N/A	N/A
PTL Inspire 500 ETF	N/A	N/A	N/A	N/A	N/A

Latest MPH, ACRL, MAV, and PTL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/4/2024	MAV Pioneer Municipal High Income Advantage Fund	monthly	$0.0325	4.7%	4/18/2024	4/19/2024	4/30/2024
3/4/2024	MAV Pioneer Municipal High Income Advantage Fund	monthly	$0.0310	4.1%	3/14/2024	3/15/2024	4/1/2024
2/6/2024	MAV Pioneer Municipal High Income Advantage Fund	Monthly	$0.0270	4%	2/15/2024	2/16/2024	2/29/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MAV Pioneer Municipal High Income Advantage Fund	N/A	N/A	N/A
MPH Medicure	2.86	2.28	1.29
PTL Inspire 500 ETF	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
MAV Pioneer Municipal High Income Advantage Fund	N/A
MPH Medicure	23.10%
PTL Inspire 500 ETF	N/A

Insider Ownership

Company	Insider Ownership
MAV Pioneer Municipal High Income Advantage Fund	N/A
MPH Medicure	26.99%
PTL Inspire 500 ETF	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
MAV Pioneer Municipal High Income Advantage Fund	N/A	N/A	N/A	Not Optionable
MPH Medicure	N/A	10.25 million	N/A	Not Optionable
PTL Inspire 500 ETF	N/A	N/A	N/A	N/A

MPH, ACRL, MAV, and PTL Headlines

Source	Headline
	Inspire's newest faith-based ETF passes $100M AUM in 11 days prnewswire.com - April 24 at 6:30 AM
	Inspire Adds Low-Cost ETF to Faith-Focused Lineup etftrends.com - March 26 at 3:45 PM

Media Sentiment Over Time

Company Descriptions

Pioneer Municipal High Income Advantage Fund

NYSE:MAV

Pioneer Municipal High Income Advantage Fund, Inc. is a closed ended fixed income mutual fund launched and managed by Pioneer Investment Management, Inc. The fund invests in the fixed income markets of the United States. It invests primarily in municipal bonds. The fund benchmarks the performance of its portfolio against the Barclays Capital High Yield Municipal Bond Index and the Barclays Capital Municipal Bond Index. It was formerly known as Pioneer Municipal Advantage Trust. Pioneer Municipal High Income Advantage Fund, Inc. was formed on August 6, 2003 and is domiciled in the United States.

Medicure

CVE:MPH

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Inspire 500 ETF

NYSEARCA:PTL

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial